Dong Fang Liu
Hoofd Techniek/Wetenschap/O&O bij NUVATION BIO INC.
Vermogen: 15 720 $ op 30-04-2024
Actieve functies van Dong Fang Liu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NUVATION BIO INC. | Hoofd Techniek/Wetenschap/O&O | 18-07-2022 | - |
Loopbaan van Dong Fang Liu
Eerdere bekende functies van Dong Fang Liu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| 3D MEDICINES INC. | Hoofd Techniek/Wetenschap/O&O | 11-01-2019 | 01-03-2021 |
| CELGENE | Directeur/Bestuurslid | - | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Opleiding van Dong Fang Liu
| Beijing Medical University | Undergraduate Degree |
| University of Toledo (Ohio) | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Kaaimaneilanden | 2 |
| China | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| 3D MEDICINES INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| NUVATION BIO INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Beurs
- Insiders
- Dong Fang Liu
- Ervaring
